by Coenraad K van Kalken, CEO, Qurin Diagnostics
Cancer is a final stage of a process characterized by accumulation of epigenetic and genetic alterations. Early detection increases the chances of a positive treatment outcome and cure of the disease. As cancer represents a large burden to society, there is an urgent need for accurate, affordable and easy-to-use diagnostic tests to detect these diseases at the doctor’s office, which is what we are aiming for using a urine-based DNA test.
The primary aim of the collaborative initiative presented, is the development of a low-threshold and noninvasive diagnostic test using DNA biosensors based on state-of-the-art photonics technology and innovative chemical nanocoatings, combined with biomarker panels specific for multiple cancer types.Continue reading “Early detection of cancer in urine using photonic biosensors”